CVE-2025-68075: CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in Kerry BNE Testimonials
Contributor Cross Site Scripting (XSS) in BNE Testimonials <= 2.0.8 versions.
AI Analysis
Technical Summary
This vulnerability (CVE-2025-68075) is a CWE-79 type cross-site scripting flaw in Kerry BNE Testimonials versions <= 2.0.8. It arises from improper input neutralization when generating web pages, enabling an attacker with contributor-level privileges to inject malicious scripts. The CVSS 3.1 base score is 6.5 (medium), reflecting network attack vector, low attack complexity, required privileges, user interaction, and partial impact on confidentiality, integrity, and availability. No vendor advisory or patch is currently available, and no known exploits are reported in the wild.
Potential Impact
Successful exploitation could allow an attacker with contributor privileges to execute arbitrary scripts in the context of users viewing the affected pages, potentially leading to partial disclosure of information, modification of content, or disruption of service. The impact is limited by the need for user interaction and contributor-level privileges.
Mitigation Recommendations
Patch status is not yet confirmed — check the vendor advisory for current remediation guidance. Until an official fix is released, consider restricting contributor permissions and sanitizing inputs at the application level if possible.
CVE-2025-68075: CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in Kerry BNE Testimonials
Description
Contributor Cross Site Scripting (XSS) in BNE Testimonials <= 2.0.8 versions.
CVSS v3.1
Score 6.5medium
Affected software
Weaknesses
AI-Powered Analysis
Machine-generated threat intelligence
Technical Analysis
This vulnerability (CVE-2025-68075) is a CWE-79 type cross-site scripting flaw in Kerry BNE Testimonials versions <= 2.0.8. It arises from improper input neutralization when generating web pages, enabling an attacker with contributor-level privileges to inject malicious scripts. The CVSS 3.1 base score is 6.5 (medium), reflecting network attack vector, low attack complexity, required privileges, user interaction, and partial impact on confidentiality, integrity, and availability. No vendor advisory or patch is currently available, and no known exploits are reported in the wild.
Potential Impact
Successful exploitation could allow an attacker with contributor privileges to execute arbitrary scripts in the context of users viewing the affected pages, potentially leading to partial disclosure of information, modification of content, or disruption of service. The impact is limited by the need for user interaction and contributor-level privileges.
Mitigation Recommendations
Patch status is not yet confirmed — check the vendor advisory for current remediation guidance. Until an official fix is released, consider restricting contributor permissions and sanitizing inputs at the application level if possible.
Technical Details
- Data Version
- 5.2
- Assigner Short Name
- Patchstack
- Date Reserved
- 2025-12-15T10:01:24.072Z
- Cvss Version
- 3.1
- State
- PUBLISHED
- Remediation Level
- null
Threat ID: 6a3e95a26e08203f7da558eb
Added to database: 06/26/2026, 15:07:14 UTC
Last enriched: 07/03/2026, 22:22:57 UTC
Last updated: 08/10/2026, 00:41:12 UTC
Views: 44
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Actions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
External Links
Need more coverage?
Upgrade to Pro Console for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.
Latest Threats
Check if your credentials are on the dark web
Instant breach scanning across billions of leaked records. Free tier available.